NPR and BioTech Nation interview Sutro’s CEO William Newell to learn more about the next generation of cancer therapeutics. Click here to listen to the conversation as Bill describes Sutro’s discovery and development efforts combining targeted warheads and ADC’s in our ground breaking efforts.